BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3344744)

  • 1. Nitrogen losses and cephalothin absorption in peritonitis treated by hourly peritoneal dialysis.
    Rubin J; Adair C
    Am J Kidney Dis; 1988 Mar; 11(3):214-9. PubMed ID: 3344744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein losses and tobramycin absorption in peritonitis treated by hourly peritoneal dialysis.
    Rubin J; Deraps GD; Walsh D; Adair C; Bower J
    Am J Kidney Dis; 1986 Aug; 8(2):124-7. PubMed ID: 3740060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis.
    Rubin J; Ray R; Barnes T; Bower J
    Nephron; 1981; 29(3-4):124-7. PubMed ID: 7329486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal kinetics in children undergoing continuous ambulatory/cycling peritoneal dialysis.
    von Lilien T; Salusky IB; Little RJ; Alliapolous JC; Leichter HE; Hall TL; Fine RN
    Am J Kidney Dis; 1987 Dec; 10(6):431-8. PubMed ID: 3120579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.
    Breborowicz A; Polubinska A; Moberly J; Ogle K; Martis L; Oreopoulos D
    Am J Kidney Dis; 2001 Mar; 37(3):594-600. PubMed ID: 11228185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.
    Rubin J; Nolph K; Arfania D; Brown P; Prowant B
    Kidney Int; 1979 Nov; 16(5):619-23. PubMed ID: 548605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrate in stable CAPD patients and during peritonitis.
    Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT
    Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
    Davies SJ; Bryan J; Phillips L; Russell GI
    Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis during peritonitis.
    Rubin J; McFarland S; Hellems EW; Bower JD
    Kidney Int; 1981 Mar; 19(3):460-4. PubMed ID: 7241884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Losses and Urea Nitrogen Underestimate Total Nitrogen Losses in Peritoneal Dialysis and Hemodialysis Patients.
    Salame C; Eaton S; Grimble G; Davenport A
    J Ren Nutr; 2018 Sep; 28(5):317-323. PubMed ID: 29709365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysate flow rate and peritoneal clearance.
    Rubin J; Adair C; Barnes T; Bower J
    Am J Kidney Dis; 1984 Nov; 4(3):260-7. PubMed ID: 6496469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients.
    Westra WM; Kopple JD; Krediet RT; Appell M; Mehrotra R
    Perit Dial Int; 2007; 27(2):192-5. PubMed ID: 17299157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin absorption from the peritoneal cavity during dialysis-related peritonitis.
    Rubin J
    Perit Dial Int; 1990; 10(4):283-5. PubMed ID: 2096929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased protein loss during peritonitis associated with peritoneal dialysis is neutrophil dependent.
    Luo Q; Cheung AK; Kamerath CD; Reimer LG; Leypoldt JK
    Kidney Int; 2000 Apr; 57(4):1736-42. PubMed ID: 10760110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models to assess nitrogen losses in pediatric patients on chronic peritoneal dialysis.
    Edefonti A; Picca M; Damiani B; Loi S; Consalvo G; Giani M; Ghio L; Origgi G; Ferrario M
    Pediatr Nephrol; 2000 Nov; 15(1-2):25-30. PubMed ID: 11095006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis.
    Blumenkrantz MJ; Kopple JD; Moran JK; Grodstein GP; Coburn JW
    Kidney Int; 1981 Jul; 20(1):78-82. PubMed ID: 7300117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tidal peritoneal dialysis for home-treated patients: should it be preferred?
    Vychytil A; Lilaj T; Schneider B; Hörl WH; Haag-Weber M
    Am J Kidney Dis; 1999 Feb; 33(2):334-43. PubMed ID: 10023647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S; Iliescu EA; Morton AR
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of peritoneal urea clearance in continuous ambulatory peritoneal dialysis (18 months experience with CAPD).
    De Santo NG; Capodisaca G; Senatore R; Cicchetti T; Cirillo D; Damiano M; Giordano C
    Int J Artif Organs; 1979 Jul; 2(4):193-6. PubMed ID: 457303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylcholine and peritoneal transport during peritoneal dialysis.
    Di Paolo N; Buoncristiani U; Capotondo L; Gaggiotti E; De Mia M; Rossi P; Sansoni E; Bernini M
    Nephron; 1986; 44(4):365-70. PubMed ID: 3796777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.